# Obat

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/obat

- Industry: Software
- Headquarters: Nantes, France
- Website: www.obat.fr
- Total disclosed funding: $7.3M
- Latest round: Series A (Apr 16, 2024)
- Investors on record: 7

## About

Founded in 2019 by Franck Asseray, and based in Nantes, France, Obat SAS is a software provider for construction contractors and self-employed professionals that helps them with invoices and quotations and digitizing all operations related to construction. In September 2022, Obat SAS raised EUR 6 million in venture funding from new investors Evolem, Holnest, and Truffle Capital. As of September 2022, the company has around 62 employees.

Obat implements a SaaS (Software as a Service) system that digitizes construction professionals' administration and procedures. The software offers services such as customer interactions, site monitoring, financial management, accounting, and personnel and human resource management.

The firm charges 32 € HT/ month and 25 € HT/ month for an annual plan of its software.

## Funding rounds

- Series A, Apr 16, 2024, $7.3M — Truffle Capital, Credit Mutuel Equity, NewAlpha Asset Management, Evolem, Kima Ventures, NCI, Holnest

## Investors

- Truffle Capital (https://capitalatlas.ai/funds/truffle-capital) — Series A
- Credit Mutuel Equity (https://capitalatlas.ai/funds/credit-mutuel-equity) — Series A
- NewAlpha Asset Management (https://capitalatlas.ai/funds/newalpha-asset-management) — Series A
- Evolem — Series A
- Kima Ventures (https://capitalatlas.ai/funds/kima-ventures) — Series A
- NCI (https://capitalatlas.ai/funds/nci) — Series A
- Holnest — Series A